申请人:GlaxoSmithKline LLC
公开号:US20140100255A1
公开(公告)日:2014-04-10
Novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, pharmaceutical compositions containing them, to processes for their preparation.
小说化合物,它们是阿片受体中一个或多个拮抗剂或反向激动剂,包含它们的制药组合物,以及它们的制备过程。